{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:49:12Z","timestamp":1791582552991,"version":"4.3.4"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.2169\/internalmedicine.9768-22","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:10:04Z","timestamp":1668550204000},"page":"1999-2004","source":"Crossref","is-referenced-by-count":3,"title":["Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis C"],"prefix":"10.2169","volume":"62","author":[{"given":"Michinori","family":"Ishitoku","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Postgraduate Clinical Training Center, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Yorishima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Mokuda","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"},{"name":"Department of Rheumatology, Medical Corporation JR Hiroshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Desbois AC, Comarmond C, Saadoun D, Cacoub P. Cryoglobulinemia vasculitis: how to handle. Curr Opin Rheumatol 29: 343-347, 2017.","DOI":"10.1097\/BOR.0000000000000390"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. Am J Med 57: 775-788, 1974.","DOI":"10.1016\/0002-9343(74)90852-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gulli F, Santini SA, Napodano C, et al. Cryoglobulin test and cryoglobulinemia hepatitis C-virus related. Mediterr J Hematol Infect Dis 9: e2017007, 2016.","DOI":"10.4084\/mjhid.2017.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cacoub P, Lidove O, Maisonobe T, et al. Interferon-\u03b1 and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46: 3317-3326, 2002.","DOI":"10.1002\/art.10699"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Landau DA, Saadoun D, Halfon P, et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 58: 604-611, 2008.","DOI":"10.1002\/art.23305"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bazari H, Mahindra AK, Farkash EA. Case records of the Massachusetts General Hospital. Case 3-2014. A 61-year-old woman with gastrointestinal symptoms, anemia, and acute kidney injury. N Engl J Med 370: 362-373, 2014.","DOI":"10.1056\/NEJMcpc1214220"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pozzato G, Mazzaro C, Artemova M, et al. Direct-acting antiviral agents for hepatic C virus-mixed cryoglobulinemia: dissociated virological and hematological responses. Br J Haematol 191: 775-783, 2020.","DOI":"10.1111\/bjh.17036"},{"key":"8","unstructured":"8. Levine JW, Gota C, Fessler BJ, et al. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 32: 1164-1167, 2005."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lerat H, Hollinger FB. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis 189: 3-6, 2004.","DOI":"10.1086\/380203"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wadstr\u00f6m H, Frisell T, Askling JAnti-Rheumatic Therapy in Sweden (ARTIS) Study Group. Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide cohort study from Sweden. JAMA Intern Med 177: 1605-1612, 2017.","DOI":"10.1001\/jamainternmed.2017.4332"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vilarrasa E, Puig L. Monoclonal gammopathy of underterminated significance (MGUS) in patients with psoriasis may be associeted with long-term treatment with efalizumab, but not with anti-TNF-\u03b1 treatments or ustekinumab. J Eur Acad Dermatol Venereol 29: 609-611, 2015.","DOI":"10.1111\/jdv.12409"},{"key":"12","unstructured":"12. Sekiguchi Y, Shimada A, Ichikawa K, et al. Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature. Int J Clin Exp Pathol 8: 2090-2102, 2015."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330: 751-756, 1994.","DOI":"10.1056\/NEJM199403173301104"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hayashi K, Ishigami M, Yasuda S, et al. Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy. Hepatol Res 48: E78-E86, 2018.","DOI":"10.1111\/hepr.12929"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lotfi AA, Mohamed AE, Shalaby NA, et al. Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders. Int J Immunopathol Pharmacol 34: 2058738420961202, 2020.","DOI":"10.1177\/2058738420961202"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Trejo O, Ramos-Casals M, Garc\u00eda-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252-262, 2001.","DOI":"10.1097\/00005792-200107000-00004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Foessel L, Besancenot JF, Blaison G, et al. Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection. J Rheumatol 38: 716-722, 2011.","DOI":"10.3899\/jrheum.100898"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Koga T, Kawashiri SY, Nakao K, Kawakami A. Successful ledipasvir + sofosbuvir treatment of active synovitis in a rheumatoid arthritis patient with hepatitis C virus-related mixed cryoglobulinemia. Mod Rheumatol 27: 917-918, 2017.","DOI":"10.1080\/14397595.2016.1253814"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 3: 25, 2008.","DOI":"10.1186\/1750-1172-3-25"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wener MH, Hutchinson K, Morishima C, Gretch DR. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50: 2305-2308, 2004.","DOI":"10.1002\/art.20355"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LEC. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 63: 191-200, 2011.","DOI":"10.1002\/art.30084"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Caviglia GP, Sciacca C, Abate ML, et al. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma. J Gastroenterol Hepatol 30: 742-747, 2015.","DOI":"10.1111\/jgh.12837"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Sethi S, Zand L, Leung N, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 5: 770-782, 2010.","DOI":"10.2215\/CJN.06760909"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Hsu JH, Fang YW, Yang AH, Tsai MH. Mixed cryoglobulinemic membranoproliferative glomerulonephritis due to monoclonal gammopathy of undetermined significance: a case report. Medicine (Baltimore) 97: e12416, 2018.","DOI":"10.1097\/MD.0000000000012416"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Ioannou GN, Green PK, Berry K, Graf SA. Eradication of hepatitis C virus is associated with reduction in hematologic malignancies: major differences between interferon and direct-acting antivirals. Hepatol Commun 3: 1124-1136, 2019.","DOI":"10.1002\/hep4.1389"},{"key":"26","doi-asserted-by":"publisher","unstructured":"27. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinemias. Lancet 379: 348-360, 2012.","DOI":"10.1016\/S0140-6736(11)60242-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/13\/62_9768-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:32:48Z","timestamp":1715315568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/13\/62_9768-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9768-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"article-number":"9768-22"}}